New insights into the antiviral effects of chloroquine

Lancet Infectious Diseases

Volumn 6, Issue 2, 2006, Pages 67-69

  Savarino, Andrea ^a   Di Trani, Livia ^b   Donatelli, Isabella ^b   Cauda, Roberto ^a   Cassone, Antonio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIDANOSINE; HYDROXYCHLOROQUINE; HYDROXYUREA; LAMIVUDINE; QUINOLINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RNA DIRECTED DNA POLYMERASE INHIBITOR; SIALIC ACID; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RETINOPATHY; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SHORT SURVEY; VIRUS LOAD; VIRUS REPLICATION;

EID: 31344436483     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70361-9     Document Type: Letter

References (15)

1. A Savarino, JR Boelaert, A Cassone, G Majori, R Cauda Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 3 2003 722 727
2. SR Joshi, N Butala, MR Patwardhan, NG Daver, D Kelkar Low cost anti-retroviral options: chloroquine based ARV regimen combined with hydroxyurea and lamivudine: a new economical triple therapy J Assoc Phys India 52 2004 597 598
3. F Lori, A Foli, A Groff Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms AIDS 19 2005 1173 1181
4. NI Paton, J Aboulhab Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks HIV Med 6 2005 13 20
5. Luchters SMF, Veldhuijzen NJ, Nsanzabera D. et al. A phase I/II randomised placebo controlled study to evaluate chloroquine administration to reduce HIV-1 RNA in breast milk in an HIV-1 infected breastfeeding population: the CHARGE Study. XV International Conference on AIDS; Bangkok, Thailand; July 11-16, 2004. Abstract TuPeB4499.
6. A Savarino, MB Lucia, E Rastrelli Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors J Acquir Immune Defic Syndr 35 1996 223 232
7. E Keyaerts, L Vijgen, P Maes, J Neyts, M Van Ranst In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Biochem Biophys Res Commun 323 2004 264 268
8. MJ Vincent, E Bergeron, S Benjannet Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Virol J 2 2005 69
9. DK Miller, J Lenard Antihistaminics, local anesthetics, and other amines as antiviral agents Proc Natl Acad Sci USA 78 1981 3605 3609
10. M Shibata, H Aoki, T Tsurumi Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine J Gen Virol 64 1983 1149 1156
11. I Donatelli, L Campitelli, L Di Trani Characterization of H5N2 influenza viruses from Italian poultry J Gen Virol 82 2001 623 630
12. G Jones, P Willett, RC Glen, AR Leach, R Taylor Development and validation of a genetic algorithm for flexible docking J Mol Biol 267 1997 727 748
13. JJ Kwiek, TA Haystead, J Rudolph Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines Biochemistry 43 2004 4538 4547
14. National Center for Biotechnology Information MMDB - Entrez's Structure Database http://www.ncbi.nlm.nih.gov/Structure/MMDB/mmdb.shtml (accessed Dec 14, 2005)
15. S Olofsson, U Kumlin, K Dimock, N Arnberg Avian influenza and sialic acid receptors: more than meets the eye? Lancet Infect Dis 5 2005 184 188